Charles River Laboratories CRL Additional Paid-In Capital
Additional Paid-In Capital at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's additional paid-in capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's additional paid-in capital?
- Charles River Laboratories (CRL) reported additional paid-in capital of $1.97B in Q1 2026.
- How has Charles River Laboratories's additional paid-in capital changed year-over-year?
- Charles River Laboratories's additional paid-in capital decreased by 0.5% year-over-year, from $1.98B to $1.97B.
- What is the long-term trend for Charles River Laboratories's additional paid-in capital?
- Over 5 years (2020 to 2025), Charles River Laboratories's additional paid-in capital has grown at a 3.7% compound annual growth rate (CAGR), from $1.63B to $1.95B.